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ABSTRACT 
 
The Effects of Stone Fruit Extract on the Process of Platelet Aggregation in Vitro.  
(July 2011)  
 
Peter M. deLeeuw 
Department of Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Dr. Luis Cisneros-Zevallos 
Department of Horticulture 
 
This project attempts to examine the impact stone fruits can have on the clotting of blood 
in the human body. Plum rich anthocyanin extract (RAE) was added in different 
concentrations (1-25µg/ml) to rabbit platelets suspended in Tyrode’s buffer and mixed in 
microplate wells. Platelet aggregation was then induced by 5 µM ADP (Adenosine 
Diphosphate), and the percent of transmittance was measured by a microplate reader. A 
change in aggregation of over 10% was recorded. The results suggest that the extract 
inhibits the aggregation caused by ADP. This would also lead one to believe that there 
are compounds in stone fruits that could lower the chances of cardiovascular disease by 
limiting aggregation and subsequently inflammation in arterial walls.  
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NOMENCLATURE 
 
A Absorbance 
ADP Adenosine Diphosphate 
C Degrees Celsius 
GP Glycoprotein 
PRP Platelet Rich Plasma 
RAE Rich Anthocyanin Extract 
Resv. Resveratrol 
T Transmittance 
TFA Triflouroacetic Acid 
TXA2 Thromboxane A2 
vWF von Willebrand Factor 
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CHAPTER I 
INTRODUCTION 
 
Cardiovascular diseases are one of the leading causes of death in the United States. 
Many factors play a role in the onset of these diseases, but recent research has shown 
that platelets are a critical component in the inflammatory response of arterial walls (1). 
This inflammation can lead to atheroprogression and atherosclerotic lesions. In fact, 
heart attacks and strokes are caused due to the platelets main function - blood clots. In 
previous studies, peaches and plums were proven to contain antioxidants that had 
anticancer capabilities (2). Similar stone fruits were now tested to see if their phenolic 
compounds also have anti- platelet properties. It has already been discovered that 
Resveratrol, a phenolic compound found in grapes has an inhibitory affect on the 
aggregation process (3).This research project hopes to prove that certain plum varieties 
contain anthocyanins that inhibit platelet aggregation similar to the drugs on the market 
like Aspirin and Plavix. The human body retains compounds that bind to receptors on 
the surface of platelets. This binding causes a cascade of events including shape change 
and the release of more agonists. Figure 1 (4), illustrates the biochemical pathways 
involved when inducing platelet aggregation. When blood vessel walls in the body are 
damaged, collagen is exposed to blood. Platelets are able to bind to the collagen directly  
_______________ 
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Figure 1. Platelet Aggregation Biochemical Pathways. This diagram shows the 
metabolites in the body that initiate platelet aggregation, the receptors on the platelet 
surface, and the cascade of events that occur. It includes ADP binding to the P2Y1 and 
P2Y12 sites on the platelet’s surface. 
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through receptors α2β1, and Glycoprotein (GP) VI. GP Ib-V-IX complex also adheres to 
collagen, but requires a ligand called von Willebrand Factor (vWF) to complete the 
process. After adhesion has taken place, platelets will then release the contents of their 
dense and α granules, which include ADP. Activated platelets will also create thrombin 
and Thromboxane A2 (TXA2.) ADP, thrombin, and TXA2 all bind to specific receptors 
on the platelet’s surface, causing signal transduction events that lead to GPIIb-IIIa 
entering an active state. GPIIb-IIIa is responsible for binding to fibrinogen and 
subsequently other platelets. ADP was chosen because it is involved in many stages of 
the aggregation process. In the body, ADP can initiate platelet activation and 
aggregation. It is also involved in the second wave of aggregation, as well as ADP 
release from platelet granules (5). A compound that inhibits ADP activated aggregation 
would halt the whole aggregation process, rather than just the beginning or end. In the 
past, platelet aggregation was measured by a machine called a platelet aggregometer. 
Recent research has been able to reproduce the same results by using a microplate reader 
(6). This gives the ability to run multiple samples at the same time, with very controlled 
conditions. Depending on the results of this project, plums could be proven to be 
essential to the diet of many individuals. If the results show a strong inhibitory effect, 
then further research could be done to isolate the specific anthocyanins responsible.  
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CHAPTER II 
METHODS 
 
Rich anthocyanin extract preparation 
The stone fruit solutions were extracted using a protocol from Dr. Cisneros’ Food 
Science Lab, which was created by Paula Simons. Stone fruit extract was taken from 
Black Splendor Plums grown in California. Once the plums arrived they were pitted and 
stored in -80C until used. 250 grams of fruit were homogenized with 580 ml of 
methanol, and stored in 4C for 24 hrs. These samples were then centrifuged at 29000 x g 
for 15 min, and the supernatant was evaporated at 35C using a rotavapor (Bϋchi, 
Switzerland). Remaining aqueous solution was re-diluted into 0.1% TFA and loaded into 
a SEP Pack c18 cartridge (10g, Waters Corp, Milford, MA). The cartridge had 
previously been conditioned to a pH below 2, with 20ml of 0.1% TFA in methanol and 
20 ml 0.1% TFA. The cartridge was washed with 100 ml of 0.1% TFA, and the RAE 
from the plums were collected with 0.1% TFA in Methanol. The methanol was 
evaporated using the same rotavapor, and the remaining aqueous solution was freeze 
dried at -50C and 200mmHg of pressure. The powder was stored at -20C until use. 
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Platelet rich plasma preparation and data collection 
Rabbit blood was acquired from the Texas A&M Comparative Tissue Department. 
Rabbit blood has been used in other papers for platelet aggregation tests, and it is 
comparable to human blood (7). The blood is drawn into tubes with 3.8% sodium citrate 
added at a 9:1 ratio. The blood must be used within 4 hours of being drawn; otherwise 
the platelets no longer aggregate effectively. Once the blood is obtained, it is centrifuged 
at 200 x g for 20 minutes. Platelet Rich Plasma (PRP) is then taken from the initial 
sample and centrifuged at 1000 x g for 20 min. The pellet of PRP created by the 
centrifugation is suspended in Tyrode’s Buffer (140mM NaCl, 10mM glucose and 
15mM Tris-HCl, pH 7.4), and then washed with the same buffer. The platelet count of 
the PRP is then taken with a hemocytometer just to confirm there is a good concentration 
of platelets (about 5x10^8 platelets/ml). The wells of a plate are then filled with 110µl of 
PRP, and different concentrations of extract from 1-25µg/ml. Some wells will just have 
120ul of PRP to be controls for zero aggregation respectively. The plate then sits at 37C 
for 30min before the test is run to incubate. Right before the plate is read by the 
microplate reader, 10µl of 5µM ADP (the agonist) is added to each well, (except the 
wells with 120µl of PRP only.) The plate reader (Biotek Synergy HT), runs at 37C, and 
measures absorbance at 595nm. The plate reader takes readings every 30 seconds, and 
shakes the plate at 20 second intervals in order to stimulate aggregation. The data is then 
turned into aggregation curves with certain calculations.  
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CHAPTER III 
RESULTS 
 
The results obtained seem to suggest that the plum rich anthocyanin extract did inhibit 
the effects of ADP and the platelet aggregation process. The science behind the use of 
the microplate reader for aggregation testing is fairly simple. The shaking of the plate 
along with the agonist (ADP) causes the platelets in the solution to clot. This clotting 
allows more light to pass through the wells of the plate, decreasing the absorbance (8). 
Absorbance (A) and transmittance (T) are inversely related through the equation  
T = 10-A. If an effective inhibitor is added to the reaction, aggregation will decrease, 
along with transmittance. The data obtained directly from the run in the microplate 
reader is shown in Figure 2. It would be expected for the wells with PRP to have the 
highest absorbance, the wells with PRP and ADP to have the lowest absorbance, and the 
wells with the inhibitors to be somewhere in between. This is not the case in the present 
study. When looking at the plates after the trial runs, a small layer of sediment was 
detected on the bottom of the wells. This means that the shaking of the plate reader and 
Tyrode’s buffer did not keep the clots evenly dispersed throughout the solution. 
Although some papers have shown to have success with plate readers (6, 9), it seems that 
not all plate readers are directly compatible in keeping the platelet aggregates in 
suspension. In previous experiments with pig blood, this exact plate reader produced 
similar results (Figure 3.) suggesting that there is a discrepancy in how the plate reader 
acquires data. Figure 4 aids in explaining why the clots sinking to the bottom of the  
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Figure 2. Absorbance vs. Time - Raw Data. This is the raw data acquired from the plate 
reader. The wells with the potential aggregation inhibitors have lower absorbances than 
PRP+ADP due to the mechanics of the plate reader and the clots sitting on the bottom of 
the wells.  
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Figure 3. Absorbance vs. Time - Pig Blood. Shows similar results to Figure 2, except 
pig blood was used and resveratrol was tested as an inhibitor.  
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Figure 4. The Mechanics Behind Absorbance Readings. This diagram explains the 
problem with the data gathering of the plate reader. Light passes vertically in the plate  
reader (a.), so when clots sink to the bottom they affect the readings. PRP+ADP would 
have had a much lower absorbance if the reading was taken horizontally like in an 
aggregometer (b.) The equations to the side of this figure (c.) also help explain the logic 
behind absorbance and transmittance. 
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wells cause an issue when using a plate reader. While aggregometers measure optical 
density in the horizontal direction, plate readers measure optical density in the vertical 
direction.  The vertical pathway of light along with the platelets lying on the base of the 
well, explain the results seen in Figure 2.  In order to correct for this problem, all of the 
different variable wells were subtracted from the control, or PRP. This creates a graph of 
delta absorbance based on the difference in absorbance of the control (Figure 5.), which 
resembles an expected aggregation test. Many times, researchers will put their data into 
the % transmittance graphs, so Figure 6 shows the delta absorbance readings after being 
converted into transmittance and multiplied by 100.  
 
Accordingly, the results show that extracts seems to drop the percent aggregation by 
about 10%. This might seem like a small decrease in aggregation, but resveratrol had 
similar effects when attempting to inhibit aggregation via ADP in previous studies (3) as 
well as in the present study (Figure 7.) using pig blood. Platelet aggregation is also 
crucial in the healing of wounds, meaning an extreme inhibition of aggregation could be 
dangerous. It is interesting to note that the different concentrations of extract made only 
minute differences in the ability to inhibit aggregation. It is possible that after a certain 
concentration of extract, the inhibition reaches a maximum effect (above 10µg/mL). 
This is promising, because it could mean that taking a less concentrated form of the 
extract could be almost as beneficial as a stronger concentration. It is also interesting that 
the 10µg/ml of plum extract inhibited aggregation the most. The difference between the 
10ug/ml and the 25ug/ml however, is very small. The major information gathered from  
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Figure 5. Delta Absorbance vs. Time. Data created by subtracting the different variables 
from PRP. This corrects values from data gathering.  
APRP – APRP +ADP = Δ A (equation indicating ADP effects) 
APRP – APRP +ADP+Plum RAE = Δ A (equation indicating ADP+ inhibitor effects) 
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Figure 6. Delta % Transmittance vs. Time. The effect of increasing concentrations of 
rich anthocyanin extract (1-25µg/ml) on platelet aggregation, agonized by ADP (5µM). 
Each curve was replicated twice with similar results.  
% T = (10-A)*100 (equation indicating effects of Δ absorbance values) 
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Figure 7. Delta % Transmittance vs. Time – Pig Blood. This graph is similar to Figure 
6, except pig blood was used and Resveratrol was the inhibitor being tested. The 
decrease in transmittance caused by Resveratrol is very similar to the decrease caused by 
Plum RAE.   
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this graph is that the extract does inhibit platelet aggregation, and the inhibition is 
significant. The degree of inhibition is dose dependent, where extreme levels of 
inhibition are unnecessary when it comes to platelet aggregation. A 10 percent decrease 
in aggregation in the present study concludes that the results are important enough to 
encourage more research in this area. Figure 8 (10), shows the precise pathway of ADP. 
The two nucleotide receptors shown are also GP-coupled receptors. The binding of ADP 
to receptor P2Y1 causes Ca2+ release, shape change, and also aides in the creation of 
TXA2. Activation of P2Y12 inhibits adenylyl cyclase, starts the secretion of dense 
granules, and aids in thromboxane and collagen mediated aggregation. The results 
suggest that the plum RAE contains compounds that bind to these receptor sites, and 
stop the aggregation process. It is interesting to note that Plavix, a very successful anti-
platelet drug, functions by binding to the P2Y12 receptor site. This site is preferred over 
the P2Y1 site because it is found almost solely in platelets, so it doesn’t affect the rest of 
the body. The P2Y1 receptor does have the potential to be a good site for an antiplatelet 
drug, but currently no clinical research has been done on specific inhibitors for the site. 
Some of the current inhibitors for these two sites must metabolize in the body before 
becoming effective, and sometimes their irreversible qualities create health risks. The 
fact that the polyphenols worked in vitro, suggests that the polyphenols are competitive 
inhibitors, and are reversible. This a great benefit of the polyphenols. If the compounds 
in the plum RAE are inhibiting only the P2Y12 site, they might have the potential to 
become critical anti-platelet drugs. 
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Figure 8. ADP Receptors. ADP binds to the receptors causing shape change and granule 
release. Our results suggest that compounds in the RAE also bind to these sites, 
inhibiting ADP and the aggregation process. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
This study showed that platelet aggregation can work in certain plate readers as long as a 
simple modification of data is conducted. This is something that has not previously been 
reported. After looking at the results of both the rabbit and pig blood with Plum RAE 
and Resveratrol, it is confirmed that the modification of data is successful, and that the 
Plum RAE has a significant inhibitory affect. The polyphenols from the plum are 
somehow blocking the ADP receptors on the surface of the platelets. This study also 
confirmed that the polyphenols are dose responsive.  With all this new information, 
Plums have the potential to be a dietary source of platelet inhibition. More research 
needs to be completed on which individual polyphenols are blocking the receptor sites, 
and which ADP receptor sites are being blocked. Future research could also look into 
different plum or stone fruit varieties. The goal of this experiment from the beginning 
was to also test peach extract, but the extraction process did not give adequate samples. 
Another path of research could test the effect of stone fruit extract on other receptors and 
pathways mentioned earlier in this paper. Continuing studies might try to use flow 
cytometry as a more accurate way to test platelet action. Although a good preliminary 
study, more research can be done on the ability of stone fruits to inhibit aggregation, and 
the compounds responsible. 
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